Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects
Men Over Age 75 Shouldn’t Be Screened For Prostate Cancer, Task Force Says
Quality Of Care Varies Widely For Prostate Cancer, Study Says
Prostatectomy Improves Outcome In Some Men
Risk of Relapse Continues After Five Years of Therapy
Two Breast Cancer Screening Methods Found Equivalent
Zometa Prevents Bone Loss In Premenopausal Women
Risk Assessment Key In Long-Term Treatment
Survey Finds Misconceptions About Cancer Worldwide
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure - Alec Kimmelman announced as next CEO and Dean of NYU Langone Health
